HESI PRACTICE EXAM-PHARM 315
EXAM QUESTIONS WITH CORRECT
ANSWERS
Which cclient cshould cthe cnurse cidentify cas cbeing cat chighest crisk cfor ccomplications
cduring cthe cuse cof can copioid canalgesic? c- cCORRECT cANS✔✔A cyoung cadult cwith
cinflammatory cbowel cdisease.
Rationale:
The cprincipal cindication cfor copioid cuse cis cacute cpain, cand ca cclient cwith
cinflammatory cbowel cdisease cis cat crisk cfor ctoxic cmegacolon cor cparalytic cileus
crelated cto cslowed cperistalsis, ca cside ceffect cof cmorphine. cAdverse ceffects cof
cmorphine cdo cnot cpose cas cgreat ca crisk cfor cclients cwith cdiabetes cor ca cfracture cas
cfor cthe cclient cwith cbowel cdisease.
The chealthcare cprovider cprescribes cdigitalis c(Digoxin) cfor ca cclient cdiagnosed cwith
cheart cfailure. cWhich cintervention cshould cthe cnurse cimplement cprior cto
cadministering cthe cdigoxin? c- cCORRECT cANS✔✔Assess cthe cserum cpotassium
clevel.
Rationale:
Hypokalemia c(decreased cserum cpotassium) cwill cprecipitate cdigitalis ctoxicity cin
cpersons creceiving cdigoxin. cThe cnurse cshould cmonitor cthe cclient's cserum cpotassium
clevels. cBlood cpressure cand crespiratory crate cwill cnot cinform cthe cnurse cabout
cpotential csafety cissues cwith cdigitalis.
A cclient cwith chyperlipidemia creceives ca cprescription cfor cniacin c(Niaspan). cWhich
cclient cteaching cis cmost cimportant cfor cthe cnurse cto cprovide? c- cCORRECT
cANS✔✔Expected cduration cof cflushing.
Rationale:
Flushing cof cthe cface cand cneck, clasting cup cto can chour, cis ca cfrequent creason cfor
cdiscontinuing cniacin. cInclusion cof cthis ceffect cin cclient cteaching cmay cpromote
ccompliance cin ctaking cthe cmedication. cWhile cnutrition ctips cand cmanaging cpruritis
care cworthwhile cinstructions cto chelp cclients cminimize cor ccope cwith cnormal cside
ceffects cassociated cwith cniacin c(Niaspan), cflushing cis cintense cand ccauses cthe cmost
cconcern cfor cthe cclient.
A cclient cwho cwas cprescribed catorvastatin c(Lipitor) cone cmonth cago ccalls cthe ctriage
cnurse cat cthe cclinic ccomplaining cof cmuscle cpain cand cweakness cin chis clegs. cWhich
cstatement creflects cthe ccorrect cdrug-specific cteaching cthe cnurse cshould cprovide cto
,cthis cclient? c- cCORRECT cANS✔✔Make can cappointment cto csee cthe chealthcare
cprovider, cbecause cmuscle cpain cmay cbe can cindication cof ca cserious cside ceffect.
Rationale:
Myopathy, csuggested cby cthe cleg cpain cand cweakness, cis ca cserious, cand cpotentially
clife-threatening, ccomplication cof cLipitor, cand cshould cbe cevaluated cimmediately cby
cthe chealthcare cprovider.
An cantacid c(Maalox) cis cprescribed cfor ca cclient cwith cpeptic culcer cdisease. cThe
cnurse cknows cthat cthe cpurpose cof cthis cmedication cis cto c- cCORRECT
cANS✔✔maintain ca cgastric cpH cof c3.5 cor cabove.
Rationale:
The cobjective cof cantacids cis cto cneutralize cgastric cacids cand ckeep cpH cof c3.5 cor
cabove cwhich cis cnecessary cfor cpepsinogen cinactivity.
Which cdosing cschedule cshould cthe cnurse cteach cthe cclient cto cobserve cfor ca
ccontrolled-release coxycodone cprescription? c- cCORRECT cANS✔✔Every c12 chours.
Rationale:
A ccontrolled-release coxycodone cprovides clong-acting canalgesia cto crelieve cmoderate
cto csevere cpain, cso ca cdosing cschedule cof cevery c12 chours cprovides cthe cbest
caround-the-clock cpain cmanagement. cControlled-release coxycodone cis cnot
cprescribed cfor cbreakthrough cpain con ca cPRN cor cas cneeded cschedule. cUsing ca
cschedule cof cevery c4 cto c6 chours cmay cjeopardize cpatient csafety cdue cto ccumulative
ceffects.
A cclient cwith costeoarthritis creceives ca cnew cprescription cfor ccelecoxib c(Celebrex)
corally cfor csymptom cmanagement. cThe cnurse cnotes cthe cclient cis callergic cto csulfa.
cWhich caction cis cmost cimportant cfor cthe cnurse cto cimplement cprior cto cadministering
cthe cfirst cdose? c- cCORRECT cANS✔✔Notify cthe chealthcare cprovider.
Rationale:
Celebrex ccontains ca csulfur cmolecule, cwhich ccan clead cto can callergic creaction cin
cindividuals cwho care csensitive cto csulfonamides, cso cthe chealthcare cprovider cshould
cbe cnotified cof cthe cclient's callergies.
The cnurse cis cassessing ca cclient cwho cis cexperiencing canaphylaxis cfrom can cinsect
csting. cWhich cprescription cshould cthe cnurse cprepare cto cadminister cthis cclient? c-
cCORRECT cANS✔✔Epinephrine.
Rationale:
Epinephrine cis can cadrenergic cagent cthat cstimulates cbeta creceptors cto cincrease
ccardiac cautomaticity cin ccardiac carrest cand crelax cbronchospasms cin canaphylaxis.
cOn cthe cither chand, cdopamine cis ca cvasopressor cused cto ctreat cclients cwith cshock.
cEphedrine ccauses cperipheral cvasoconstriction cand cis cused cin cthe ctreatment cof
, cnasal ccongestion. cDiphenhydramine cis can cantihistamine cdecongestant cused cin cthe
ctreatment cof cmild callergic creactions cand cmotion csickness. cEpinephrine cis cthe
cmedication cof cchoice cin ctreating canaphylaxis.
A cclient cis cbeing ctreated cfor costeoporosis cwith calendronate c(Fosamax), cand cthe
cnurse chas ccompleted cdischarge cteaching cregarding cmedication cadministration.
cWhich cmorning cschedule cwould cindicate cto cthe cnurse cthat cthe cclient cteaching chas
cbeen ceffective? c- cCORRECT cANS✔✔Take cmedication, cgo cfor ca c30 cminute
cmorning cwalk, cthen ceat cbreakfast.
Rationale:
Alendronate c(Fosamax) cis cbest cabsorbed cwhen ctaken cthirty cminutes cbefore ceating
cin cthe cmorning. cThe cclient cshould calso cbe cadvised cto cremain cin can cupright
cposition cfor cat cleast cthirty cminutes cafter ctaking cthe cmedication cto creduce cthe crisk
cof cesophageal creflux cand cirritation.
After cabdominal csurgery, ca cmale cclient cis cprescribed clow cmolecular cweight cheparin
c(LMWH). cDuring cadministration cof cthe cmedication, cthe cclient casks cthe cnurse cwhy
che cis creceiving cthis cmedication. cWhich cis cthe cbest cresponse cfor cthe cnurse cto
cprovide? c- cCORRECT cANS✔✔This cmedication cis ca cblood cthinner cgiven cto cprevent
cblood cclot cformation.
Rationale:
Unfractionated cheparin cor clow cmolecular cweight cheparin c(LMWH) cis can
canticoagulant cthat cinhibits cthrombin-mediated cconversion cof cfibrinogen cto cfibrin cand
cis cgiven cprophylactically cto cprevent cpostoperative cvenous cthrombosis cin corder cto
cprevent cpulmonary cembolism cor cdeep cvein cthrombosis cfollowing cknee cand
cabdominal csurgeries.
Which csymptoms care cserious cadverse ceffects cof cbeta-adrenergic cblockers csuch cas
cpropranolol c(Inderal)? c- cCORRECT cANS✔✔Wheezing, chypotension, cand cAV cblock.
Rationale:
Wheezing, chypotension, cand cAV cblock crepresents cthe cmost cserious cadverse ceffects
cof cbeta-blocking cagents. cAV cblock cis cgenerally cassociated cwith cbradycardia cand
cresults cin cpotentially clife-threatening cdecreases cin ccardiac coutput. cAdditionally,
cwheezing csecondary cto cbronchospasm cand chypotension crepresent clife-threatening
crespiratory cand ccardiac cdisorders.
Following cthe cadministration cof csublingual cnitroglycerin cto ca cclient cexperiencing can
cacute canginal cattack, cwhich cassessment cfinding cindicates cto cthe cnurse cthat cthe
cdesired ceffect chas cbeen cachieved? c- cCORRECT cANS✔✔Client cstates cchest cpain
cis crelieved.
Rationale:
EXAM QUESTIONS WITH CORRECT
ANSWERS
Which cclient cshould cthe cnurse cidentify cas cbeing cat chighest crisk cfor ccomplications
cduring cthe cuse cof can copioid canalgesic? c- cCORRECT cANS✔✔A cyoung cadult cwith
cinflammatory cbowel cdisease.
Rationale:
The cprincipal cindication cfor copioid cuse cis cacute cpain, cand ca cclient cwith
cinflammatory cbowel cdisease cis cat crisk cfor ctoxic cmegacolon cor cparalytic cileus
crelated cto cslowed cperistalsis, ca cside ceffect cof cmorphine. cAdverse ceffects cof
cmorphine cdo cnot cpose cas cgreat ca crisk cfor cclients cwith cdiabetes cor ca cfracture cas
cfor cthe cclient cwith cbowel cdisease.
The chealthcare cprovider cprescribes cdigitalis c(Digoxin) cfor ca cclient cdiagnosed cwith
cheart cfailure. cWhich cintervention cshould cthe cnurse cimplement cprior cto
cadministering cthe cdigoxin? c- cCORRECT cANS✔✔Assess cthe cserum cpotassium
clevel.
Rationale:
Hypokalemia c(decreased cserum cpotassium) cwill cprecipitate cdigitalis ctoxicity cin
cpersons creceiving cdigoxin. cThe cnurse cshould cmonitor cthe cclient's cserum cpotassium
clevels. cBlood cpressure cand crespiratory crate cwill cnot cinform cthe cnurse cabout
cpotential csafety cissues cwith cdigitalis.
A cclient cwith chyperlipidemia creceives ca cprescription cfor cniacin c(Niaspan). cWhich
cclient cteaching cis cmost cimportant cfor cthe cnurse cto cprovide? c- cCORRECT
cANS✔✔Expected cduration cof cflushing.
Rationale:
Flushing cof cthe cface cand cneck, clasting cup cto can chour, cis ca cfrequent creason cfor
cdiscontinuing cniacin. cInclusion cof cthis ceffect cin cclient cteaching cmay cpromote
ccompliance cin ctaking cthe cmedication. cWhile cnutrition ctips cand cmanaging cpruritis
care cworthwhile cinstructions cto chelp cclients cminimize cor ccope cwith cnormal cside
ceffects cassociated cwith cniacin c(Niaspan), cflushing cis cintense cand ccauses cthe cmost
cconcern cfor cthe cclient.
A cclient cwho cwas cprescribed catorvastatin c(Lipitor) cone cmonth cago ccalls cthe ctriage
cnurse cat cthe cclinic ccomplaining cof cmuscle cpain cand cweakness cin chis clegs. cWhich
cstatement creflects cthe ccorrect cdrug-specific cteaching cthe cnurse cshould cprovide cto
,cthis cclient? c- cCORRECT cANS✔✔Make can cappointment cto csee cthe chealthcare
cprovider, cbecause cmuscle cpain cmay cbe can cindication cof ca cserious cside ceffect.
Rationale:
Myopathy, csuggested cby cthe cleg cpain cand cweakness, cis ca cserious, cand cpotentially
clife-threatening, ccomplication cof cLipitor, cand cshould cbe cevaluated cimmediately cby
cthe chealthcare cprovider.
An cantacid c(Maalox) cis cprescribed cfor ca cclient cwith cpeptic culcer cdisease. cThe
cnurse cknows cthat cthe cpurpose cof cthis cmedication cis cto c- cCORRECT
cANS✔✔maintain ca cgastric cpH cof c3.5 cor cabove.
Rationale:
The cobjective cof cantacids cis cto cneutralize cgastric cacids cand ckeep cpH cof c3.5 cor
cabove cwhich cis cnecessary cfor cpepsinogen cinactivity.
Which cdosing cschedule cshould cthe cnurse cteach cthe cclient cto cobserve cfor ca
ccontrolled-release coxycodone cprescription? c- cCORRECT cANS✔✔Every c12 chours.
Rationale:
A ccontrolled-release coxycodone cprovides clong-acting canalgesia cto crelieve cmoderate
cto csevere cpain, cso ca cdosing cschedule cof cevery c12 chours cprovides cthe cbest
caround-the-clock cpain cmanagement. cControlled-release coxycodone cis cnot
cprescribed cfor cbreakthrough cpain con ca cPRN cor cas cneeded cschedule. cUsing ca
cschedule cof cevery c4 cto c6 chours cmay cjeopardize cpatient csafety cdue cto ccumulative
ceffects.
A cclient cwith costeoarthritis creceives ca cnew cprescription cfor ccelecoxib c(Celebrex)
corally cfor csymptom cmanagement. cThe cnurse cnotes cthe cclient cis callergic cto csulfa.
cWhich caction cis cmost cimportant cfor cthe cnurse cto cimplement cprior cto cadministering
cthe cfirst cdose? c- cCORRECT cANS✔✔Notify cthe chealthcare cprovider.
Rationale:
Celebrex ccontains ca csulfur cmolecule, cwhich ccan clead cto can callergic creaction cin
cindividuals cwho care csensitive cto csulfonamides, cso cthe chealthcare cprovider cshould
cbe cnotified cof cthe cclient's callergies.
The cnurse cis cassessing ca cclient cwho cis cexperiencing canaphylaxis cfrom can cinsect
csting. cWhich cprescription cshould cthe cnurse cprepare cto cadminister cthis cclient? c-
cCORRECT cANS✔✔Epinephrine.
Rationale:
Epinephrine cis can cadrenergic cagent cthat cstimulates cbeta creceptors cto cincrease
ccardiac cautomaticity cin ccardiac carrest cand crelax cbronchospasms cin canaphylaxis.
cOn cthe cither chand, cdopamine cis ca cvasopressor cused cto ctreat cclients cwith cshock.
cEphedrine ccauses cperipheral cvasoconstriction cand cis cused cin cthe ctreatment cof
, cnasal ccongestion. cDiphenhydramine cis can cantihistamine cdecongestant cused cin cthe
ctreatment cof cmild callergic creactions cand cmotion csickness. cEpinephrine cis cthe
cmedication cof cchoice cin ctreating canaphylaxis.
A cclient cis cbeing ctreated cfor costeoporosis cwith calendronate c(Fosamax), cand cthe
cnurse chas ccompleted cdischarge cteaching cregarding cmedication cadministration.
cWhich cmorning cschedule cwould cindicate cto cthe cnurse cthat cthe cclient cteaching chas
cbeen ceffective? c- cCORRECT cANS✔✔Take cmedication, cgo cfor ca c30 cminute
cmorning cwalk, cthen ceat cbreakfast.
Rationale:
Alendronate c(Fosamax) cis cbest cabsorbed cwhen ctaken cthirty cminutes cbefore ceating
cin cthe cmorning. cThe cclient cshould calso cbe cadvised cto cremain cin can cupright
cposition cfor cat cleast cthirty cminutes cafter ctaking cthe cmedication cto creduce cthe crisk
cof cesophageal creflux cand cirritation.
After cabdominal csurgery, ca cmale cclient cis cprescribed clow cmolecular cweight cheparin
c(LMWH). cDuring cadministration cof cthe cmedication, cthe cclient casks cthe cnurse cwhy
che cis creceiving cthis cmedication. cWhich cis cthe cbest cresponse cfor cthe cnurse cto
cprovide? c- cCORRECT cANS✔✔This cmedication cis ca cblood cthinner cgiven cto cprevent
cblood cclot cformation.
Rationale:
Unfractionated cheparin cor clow cmolecular cweight cheparin c(LMWH) cis can
canticoagulant cthat cinhibits cthrombin-mediated cconversion cof cfibrinogen cto cfibrin cand
cis cgiven cprophylactically cto cprevent cpostoperative cvenous cthrombosis cin corder cto
cprevent cpulmonary cembolism cor cdeep cvein cthrombosis cfollowing cknee cand
cabdominal csurgeries.
Which csymptoms care cserious cadverse ceffects cof cbeta-adrenergic cblockers csuch cas
cpropranolol c(Inderal)? c- cCORRECT cANS✔✔Wheezing, chypotension, cand cAV cblock.
Rationale:
Wheezing, chypotension, cand cAV cblock crepresents cthe cmost cserious cadverse ceffects
cof cbeta-blocking cagents. cAV cblock cis cgenerally cassociated cwith cbradycardia cand
cresults cin cpotentially clife-threatening cdecreases cin ccardiac coutput. cAdditionally,
cwheezing csecondary cto cbronchospasm cand chypotension crepresent clife-threatening
crespiratory cand ccardiac cdisorders.
Following cthe cadministration cof csublingual cnitroglycerin cto ca cclient cexperiencing can
cacute canginal cattack, cwhich cassessment cfinding cindicates cto cthe cnurse cthat cthe
cdesired ceffect chas cbeen cachieved? c- cCORRECT cANS✔✔Client cstates cchest cpain
cis crelieved.
Rationale:
